Subtopic Deep Dive
Beta-Blocker Therapy in Noncardiac Surgery
Research Guide
What is Beta-Blocker Therapy in Noncardiac Surgery?
Beta-Blocker Therapy in Noncardiac Surgery evaluates continuation, initiation, and titration strategies for beta-blockers in patients undergoing noncardiac procedures to balance cardioprotection against risks of stroke and hypotension.
POISE trial evidence drives debates on beta-blocker use perioperatively. Meta-analyses weigh myocardial infarction reduction against adverse events like hypotension. Over 10 guidelines and reviews from 2000-2018 address cardiovascular risk management in surgery.
Why It Matters
ESC/ESA 2014 Guidelines (Kristensen et al., 2014) recommend against initiating beta-blockers within 1 day before noncardiac surgery due to stroke risk from POISE data. Continuation for chronic users remains standard per ESH/ESC hypertension guidelines (Mancia et al., 2013; Williams et al., 2018). These protocols reduce perioperative cardiac events in vascular and colorectal surgery (Ricco et al., 2017; Gustafsson et al., 2018), informing ERAS protocols and hospital safety measures (Rodgers, 2000; de Vries et al., 2008).
Key Research Challenges
Stroke Risk from Initiation
POISE trial showed high-dose metoprolol started preoperatively increased stroke by 2-fold. Guidelines shifted against new starts (Kristensen et al., 2014). Balancing acute cardioprotection remains unresolved.
Hypotension in Titration
Beta-blockers cause intraoperative hypotension, elevating mortality in noncardiac cases. ESC recommendations limit aggressive titration (Kristensen et al., 2014). Optimal dosing protocols lack consensus.
Continuation vs Discontinuation
Chronic beta-blocker users face withdrawal risks if stopped preoperatively. Hypertension guidelines support continuation (Mancia et al., 2013). RCT evidence conflicts on vascular surgery subgroups.
Essential Papers
2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz et al. · 2013 · European Heart Journal · 13.6K citations
The ESH/ESC Guidelines represent the views of the ESH and ESC and were arrived at after careful consideration of the available evidence at the time they were written.Health professionals are encour...
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams, Giuseppe Mancia, Wilko Spiering et al. · 2018 · European Heart Journal · 10.1K citations
The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
Authors Task Force Members, Raimund Erbel, Victor Aboyans et al. · 2014 · European Heart Journal · 4.3K citations
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the D...
2014 ESC/EACTS Guidelines on myocardial revascularization
Stephan Windecker, Philippe Kolh, Fernándo Alfonso et al. · 2014 · European Heart Journal · 4.3K citations
peer reviewed
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Jean‐Baptiste Ricco, Marie-Louise Bartelink, Martin Björck et al. · 2017 · European Heart Journal · 3.2K citations
Document covering atherosclerotic disease of extracranial carotid \nand vertebral, mesenteric, renal, upper and lower extremity arteries
Editor's Choice – European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms
Anders Wanhainen, Fabio Verzini, Isabelle Van Herzeele et al. · 2018 · European Journal of Vascular and Endovascular Surgery · 2.2K citations
Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised
Anthony Rodgers · 2000 · BMJ · 2.1K citations
Neuraxial blockade reduces postoperative mortality and other serious complications. The size of some of these benefits remains uncertain, and further research is required to determine whether these...
Reading Guide
Foundational Papers
Start with Kristensen et al. (2014) ESC/ESA Guidelines for core recommendations against initiation, then Mancia et al. (2013) ESH/ESC for continuation rationale, and Rodgers (2000) for comparative perioperative mortality reductions.
Recent Advances
Williams et al. (2018) ESC/ESH updates (10057 citations); Gustafsson et al. (2018) ERAS colorectal guidelines; Ricco et al. (2017) peripheral artery diseases.
Core Methods
RCT analysis like POISE trial; GRADE evidence synthesis in ESC guidelines; meta-analyses of adverse events including stroke, hypotension, and mortality.
How PapersFlow Helps You Research Beta-Blocker Therapy in Noncardiac Surgery
Discover & Search
Research Agent uses searchPapers for 'beta-blocker noncardiac surgery POISE' to retrieve Kristensen et al. (2014) ESC/ESA guidelines (1631 citations), then citationGraph maps forward citations to ERAS protocols like Gustafsson et al. (2018), and findSimilarPapers uncovers related hypertension guidelines (Mancia et al., 2013).
Analyze & Verify
Analysis Agent applies readPaperContent to extract POISE trial data from Kristensen et al. (2014), uses verifyResponse (CoVe) for stroke risk claims, and runPythonAnalysis on meta-analysis odds ratios with GRADE grading to verify low-quality evidence on beta-blocker titration.
Synthesize & Write
Synthesis Agent detects gaps in continuation strategies across ESC guidelines, flags contradictions between POISE and chronic use papers, then Writing Agent uses latexEditText, latexSyncCitations for guideline tables, and latexCompile for perioperative protocol drafts with exportMermaid flowcharts.
Use Cases
"Extract hypotension rates from POISE trial beta-blocker arm using Python."
Research Agent → searchPapers(POISE) → Analysis Agent → readPaperContent → runPythonAnalysis(pandas odds ratio plot) → matplotlib graph of event rates.
"Draft LaTeX guideline on beta-blocker continuation in vascular surgery."
Synthesis Agent → gap detection → Writing Agent → latexEditText(protocol) → latexSyncCitations(Kristensen 2014, Ricco 2017) → latexCompile(PDF output).
"Find GitHub repos analyzing POISE trial meta-analyses."
Research Agent → searchPapers(POISE meta-analysis) → paperExtractUrls → paperFindGithubRepo → githubRepoInspect(R code for survival curves).
Automated Workflows
Deep Research workflow scans 50+ ESC papers via searchPapers → citationGraph → structured report on beta-blocker risks with GRADE scores. DeepScan applies 7-step CoVe to verify stroke claims from Kristensen et al. (2014) against Mancia et al. (2013). Theorizer generates titration hypotheses from guideline contradictions.
Frequently Asked Questions
What defines beta-blocker therapy in noncardiac surgery?
Strategies for continuation of chronic therapy, initiation preoperatively, or titration during noncardiac procedures to mitigate cardiac risks amid stroke and hypotension hazards.
What methods assess beta-blocker risks?
RCTs like POISE trial, meta-analyses of adverse events, and ESC guideline consensus using GRADE evidence grading (Kristensen et al., 2014).
What are key papers?
Kristensen et al. (2014) ESC/ESA guidelines (1631 citations) recommend against initiation; Mancia et al. (2013) ESH/ESC supports continuation (13632 citations); Rodgers (2000) on neuraxial alternatives (2099 citations).
What open problems exist?
Optimal titration doses without hypotension; subgroup benefits in vascular surgery; long-term outcomes post-POISE era.
Research Cardiac, Anesthesia and Surgical Outcomes with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Beta-Blocker Therapy in Noncardiac Surgery with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers